Hard to understand isn't it. Generex has been around such a long time and has some decent to good data in the studies it has done both cancer and virus related.

Joe says he believes and our scientists and expert consultants believe we have the best platform and yet we have very little to no financial backing to show for it. Even in this time of unprecedented support for virus and cancer research. Why such a disconnect? I keep hearing the excuse of: Generex is a small market cap company on the OTC. While that may be an excuse for financial backing by some investment entities, grant funding opportunities abound for companies with promising science. Makes one wonder if our science is solid, is there a problem in how we deliver the data to Gates, HHS, NIH, BARDA etc. Maybe our presentation doesn't stick out from the multitude of others.